https://clinicaltrials.gov/ct2/show/NCT02268552?type=Intr&cond=spinal+muscular+atrophy&phase=0124&lupd_s=07%2F14%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)
DESCRIPTION:
Condition: Spinal Muscular Atrophy
Intervention: Drug: branaplam
Sponsor: Novartis Pharmaceuticals
Active, not recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT02268552
FIRST POSTED:
Mon, 20 Oct 2014 12:00:00 EDT
LAST UPDATE POSTED:
07/28/20 06:54AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT02268552?type=Intr&cond=spinal+muscular+atrophy&phase=0124&lupd_s=07%2F14%2F2020&lupd_d=14&sort=nwst
